| Neuron-specific enolase as a predictor of death or poor neurological outcome after out-of-hospital cardiac arrest and targeted temperature management at 33 C and 36 C P Stammet, O Collignon, C Hassager, MP Wise, J Hovdenes, A Åneman, ... Journal of the American College of Cardiology 65 (19), 2104-2114, 2015 | 316 | 2015 |
| A novel immunoassay using recombinant allergens simplifies peanut allergy diagnosis F Codreanu, O Collignon, O Roitel, B Thouvenot, C Sauvage, AC Vilain, ... International archives of allergy and immunology 154 (3), 216-226, 2011 | 175 | 2011 |
| A panel of 4 microRNAs facilitates the prediction of left ventricular contractility after acute myocardial infarction Y Devaux, M Vausort, GP McCann, D Kelly, O Collignon, LL Ng, ... PloS one 8 (8), e70644, 2013 | 163 | 2013 |
| Current statistical considerations and regulatory perspectives on the planning of confirmatory basket, umbrella, and platform trials O Collignon, C Gartner, AB Haidich, R James Hemmings, B Hofner, ... Clinical Pharmacology & Therapeutics 107 (5), 1059-1067, 2020 | 77 | 2020 |
| Protein S100 as outcome predictor after out-of-hospital cardiac arrest and targeted temperature management at 33 C and 36 C P Stammet, J Dankiewicz, N Nielsen, F Fays, O Collignon, C Hassager, ... Critical Care 21, 1-10, 2017 | 72 | 2017 |
| Association of circulating microRNA-124-3p levels with outcomes after out-of-hospital cardiac arrest: a substudy of a randomized clinical trial Y Devaux, J Dankiewicz, A Salgado-Somoza, P Stammet, O Collignon, ... JAMA cardiology 1 (3), 305-313, 2016 | 67 | 2016 |
| Innovation in oncology clinical trial design J Verweij, HR Hendriks, H Zwierzina, V Wacheck, O Collignon, P Bruzzi, ... Cancer treatment reviews 74, 15-20, 2019 | 60 | 2019 |
| Bispectral index to predict neurological outcome early after cardiac arrest P Stammet, O Collignon, C Werer, C Sertznig, Y Devaux Resuscitation 85 (12), 1674-1680, 2014 | 48 | 2014 |
| Delayed hypersensitivity reactions caused by iodixanol: an assessment of cross-reactivity in 22 patients. F Hasdenteufel, J Waton, V Cordebar, M Studer, O Collignon, S Luyasu, ... The Journal of Allergy and Clinical Immunology 128 (6), 1356-1357, 2011 | 47 | 2011 |
| Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency O Collignon, F Koenig, A Koch, RJ Hemmings, F Pétavy, ... Trials 19, 1-14, 2018 | 36 | 2018 |
| Collaborative platform trials to fight COVID‐19: methodological and regulatory considerations for a better societal outcome O Collignon, CF Burman, M Posch, A Schiel Clinical Pharmacology & Therapeutics 110 (2), 311-320, 2021 | 31 | 2021 |
| Regulatory assessment of drug dissolution profiles comparability via maximum deviation K Moellenhoff, H Dette, E Kotzagiorgis, S Volgushev, O Collignon Statistics in medicine 37 (20), 2968-2981, 2018 | 28 | 2018 |
| TTM-Trial Investigators: Neuron-specific enolase as a predictor of death or poor neurological outcome after out-of-hospital cardiac arrest and targeted temperature management … P Stammet, O Collignon, C Hassager, MP Wise, J Hovdenes, A Åneman, ... J Am Coll Cardiol 65 (19), 2104-2114, 2015 | 26 | 2015 |
| Nonrandom variations in human cancer ESTs indicate that mRNA heterogeneity increases during carcinogenesis M Brulliard, D Lorphelin, O Collignon, W Lorphelin, B Thouvenot, E Gothié, ... Proceedings of the National Academy of Sciences 104 (18), 7522-7527, 2007 | 26 | 2007 |
| Estimands and complex innovative designs O Collignon, A Schiel, CF Burman, K Rufibach, M Posch, F Bretz Clinical Pharmacology & Therapeutics 112 (6), 1183-1190, 2022 | 18 | 2022 |
| Implementing historical controls in oncology trials O Collignon, A Schritz, R Spezia, SJ Senn The Oncologist 26 (5), e859-e862, 2021 | 18 | 2021 |
| Target Temperature Management after Out-of-Hospital Cardiac Arrest (TTM) trial investigators. Protein S100 as outcome predictor after out-of-hospital cardiac arrest and … P Stammet, J Dankiewicz, N Nielsen, F Fays, O Collignon, C Hassager, ... Crit Care 21 (1), 153, 2017 | 17 | 2017 |
| Clustered allocation as a way of understanding historical controls: Components of variation and regulatory considerations O Collignon, A Schritz, SJ Senn, R Spezia Statistical methods in medical research 29 (7), 1960-1971, 2020 | 9 | 2020 |
| Methodological issues in the design of a rheumatoid arthritis activity score and its cut-offs O Collignon Clinical epidemiology, 221-226, 2014 | 8 | 2014 |
| Equivalence analyses of dissolution profiles with the mahalanobis distance: a regulatory perspective and a comparison with a parametric maximum deviation‐based approach O Collignon, K Moellenhoff, H Dette Biometrical Journal 61 (3), 779-782, 2019 | 7 | 2019 |
